作者: Kawamura, Kazunori ; Nengaki, Nobuki ; Mori, Wakana ; Kurihara, Yusuke ; Kokufuta, Tomomi ; Zhang, Ming-Rong ; Yamasaki, Tomoteru ; Fujinaga, Masayuki ; Ogawa, Masanao ; Tsukagoe, Kaito ; Zhang, Yiding

BACKGROUNDA family of BF₂-chelated tetraaryl-azadipyrromethenes was developed as non-porphyrin photosensitizers for photodynamic therapy. Among the developed photosensitizers, ADPM06 exhibited excellent photochemical and photophysical properties. Molecular imaging is a useful tool for photodynamic therapy planning and monitoring. Radiolabeled photosensitizers can efficiently address photosensitizer biodistribution, providing helpful information for photodynamic therapy planning. To evaluate the biodistribution of ADPM06 and predict its pharmacokinetics on photodynamic therapy with light irradiation immediately after administration, we synthesized [¹⁸F]ADPM06 and evaluated its in vivo properties.RESULTS[¹⁸F]ADPM06 was automatically synthesized by Lewis acid-assisted isotopic ¹⁸F-¹⁹F exchange using ADPM06 and tin (IV) chloride at room temperature for 10 min. Radiolabeling was carried out using 0.4 μmol of ADPM06 and 200 μmol of tin (IV) chloride. The radiosynthesis time was approximately 60 min, and the radiochemical purity was > 95% at the end of the synthesis. The decay-corrected radiochemical yield from [¹⁸F]F^- at the start of synthesis was 13 ± 2.7% (n = 5). In the biodistribution study of male ddY mice, radioactivity levels in the heart, lungs, liver, pancreas, spleen, kidney, small intestine, muscle, and brain gradually decreased over 120 min after the initial uptake. The mean radioactivity level in the thighbone was the highest among all organs investigated and increased for 120 min after injection. Upon co-injection with ADPM06, the radioactivity levels in the blood and brain significantly increased, whereas those in the heart, lung, liver, pancreas, kidney, small intestine, muscle, and thighbone of male ddY mice were not affected. In the metabolite analysis of the plasma at 30 min post-injection in female BALB/c-nu/nu mice, the percentage of radioactivity corresponding to [¹⁸F]ADPM06 was 76.3 ± 1.6% (n = 3). In a positron emission tomography study using MDA-MB-231-HTB-26 tumor-bearing mice (female BALB/c-nu/nu), radioactivity accumulated in the bone at a relatively high level and in the tumor at a moderate level for 60 min after injection.CONCLUSIONSWe synthesized [¹⁸F]ADPM06 using an automated ¹⁸F-labeling synthesizer and evaluated the initial uptake and pharmacokinetics of ADPM06 using biodistribution of [¹⁸F]ADPM06 in mice to guide photodynamic therapy with light irradiation.

2020-09-10·Journal of Medicinal Chemistry1区 · 医学

Discovery of a Monoiodo Aza-BODIPY Near-Infrared Photosensitizer: in vitro and in vivo Evaluation for Photodynamic Therapy

1区 · 医学

Article

作者: Zhao, Weili ; Lin, Guangyu ; Yu, Zhiliang ; Dong, Xiaochun ; Ji, Xin ; Zhou, Junliang ; Xu, Shuang

Photodynamic therapy (PDT) as a rising platform of the cancer treatment method is receiving increased attention. Through systematic evaluation of halogen substitution on aza-4,4-difluoro-4-bora-3a,4a-diaza-s-indacenes (BODIPY), we have found that monoiodo-derived aza-BODIPYs provided greater efficacy than other halogenated aza-BODIPY PSs. 4 and 15 as monoiodinated aza-BODIPY dyes containing p-methoxyphenyl moiety were identified to be potent NIR aza-BODIPY-type PSs with IC₅₀ values against HeLa cells at a light dose of 54 J/cm² as low as 76 and 81 nM, respectively. 4 possessed superior phototoxicity, low dark toxicity, and good thermal/photostability and distributed majorly in mitochondria in cells. Apoptosis was verified to be the main cell death pathway, and in vitro reactive oxygen species generation was demonstrated. In vivo whole-body fluorescence imaging and ex vivo organ distribution studies suggested that 4 afforded an excellent PDT effect with a low drug dose under single-time light irradiation and revealed advantages over known PSs of ADPM06 and Ce6.

2012-02-01·International Journal of Cancer1区 · 医学

Mechanism of cell death mediated by a BF₂‐chelated tetraaryl‐azadipyrromethene photodynamic therapeutic: Dissection of the apoptotic pathway in vitro and in vivo

1区 · 医学

Article

作者: Gallagher, William M. ; Byrne, Annette T. ; O'Connor, Aisling E. ; Ponomarev, Vladimir ; McGee, Margaret M. ; Likar, Yury ; O'Shea, Donal F. ; Callanan, John J.

AbstractPhotodynamic therapy (PDT) is an established treatment modality for cancer. ADPM06 is an emerging non‐porphyrin PDT agent which has been specifically designed for therapeutic application. Recently, we have demonstrated that ADPM06‐PDT is well tolerated in vivo and elicits impressive complete response rates in various models of cancer when a short drug‐light interval is applied. Herein, the mechanism of action of ADPM06‐PDT in vitro and in vivo is outlined. Using a drug and light combination that reduces the clonogenicity of MDA‐MB‐231 cells by >90%, we detected a well‐orchestrated apoptotic response accompanied by the activation of various caspases in vitro. The generation of reactive oxygen species (ROS) upon photosensitizer irradiation was found to be the key instigator in the observed apoptotic response, with the endoplasmic reticulum (ER) found to be the intracellular site of initial PDT damage, as determined by induction of a rapid ER stress response post‐PDT. PDT‐induced apoptosis was also found to be independent of p53 tumor suppressor status. A robust therapeutic response in vivo was demonstrated, with a substantial reduction in tumor proliferation observed, as well as a rapid induction of apoptosis and initiation of ER stress, mirroring numerous aspects of the mechanism of action of ADPM06 in vitro. Finally, using a combination of 18F‐labeled 3′‐deoxy‐3′‐fluorothymidine (18F‐FLT) nuclear and optical imaging, a considerable decrease in tumor proliferation over 24‐hr in two models of human cancer was observed. Taken together, this data clearly establishes ADPM06 as an exciting novel PDT agent with significant potential for further translational development.

100 项与 ADPM-06 相关的药物交易

登录后查看更多信息